NCT07568457

Brief Summary

The goal of this study is to test whether providing various social resources (transportation support through Lyft rides, housing support through Hyatt House LA, and meal support through Project Angel Food LA) will reduce treatment delays and increase treatment uptake for patients with liver cancer.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
27mo left

Started Jun 2026

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2026

Completed
22 days until next milestone

First Posted

Study publicly available on registry

May 5, 2026

Completed
27 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2028

3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

May 5, 2026

Status Verified

April 1, 2026

Enrollment Period

2 years

First QC Date

April 13, 2026

Last Update Submit

April 30, 2026

Conditions

Keywords

HCCSocial Determinants of HealthSDOHhealth servicesinterventional trialtransportation

Outcome Measures

Primary Outcomes (1)

  • Proportion of participants with treatment uptake within 90 days

    The primary outcome is receipt of timely treatment for HCC defined as within 90 days of randomization

    90 days

Secondary Outcomes (5)

  • Proportion receiving treatment

    2 years

  • Number of acute care visits

    2 years

  • Patient-reported outcome - FACIT-COST Survey

    6 months

  • Patient reported outcome - FACT-HEP Survey

    6 months

  • Mortality

    2 years

Study Arms (2)

SDOH and patient navigation program

EXPERIMENTAL

Transportation support through Lyft rideshares, housing support through Hyatt House LA - University Medical Center, and meal support through Project Angel Food LA

Other: Social Determinants of Health ProgramOther: Patient Navigation

Patient navigation only

ACTIVE COMPARATOR

For the duration of the intervention, patients will have access to patient navigation as per usual care. The intensity and frequency of navigation is dependent on the treating clinic; the provider of navigation (whether nurse vs social worker) is also variable by clinic. This includes: coordination of care including assistance with scheduling follow-up visits, labs, imaging, and procedures, help with filling out forms for insurance, FMLA or disability benefits, facilitating communication with treating providers, referral to community and patient support groups, providing patients with educational materials and resources, check-ins on well-being and any cancer- or treatment-related concerns

Other: Patient Navigation

Interventions

Social resources to be offered under our SDOH program will include 1) rideshares to treatment-related visits, 2) hotel stays for treatment-related visits, and/or 3) a 12-week meal delivery program.

SDOH and patient navigation program

Usual clinic-provided patient navigation to appointments, scheduling, social resources, financial challenges, etc.

Patient navigation onlySDOH and patient navigation program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (18 years or older)
  • Diagnosis of HCC (BCLC Stage A-C)
  • Uninsured or underinsured (i.e., Medicaid as primary or secondary insurance)
  • Able to provide informed consent

You may not qualify if:

  • Non-HCC liver tumors
  • BCLC Stage D and/or Child Pugh C cirrhosis (latter unable to receive treatment due to poor liver function)
  • No plans for cancer treatment for any reason including patient refusal (best supportive care only)
  • Only oral systemic therapy planned (i.e., tyrosine kinase inhibitors)
  • Incarcerated patients or pregnant patients
  • Unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Keck Hospital of USC

Los Angeles, California, 90033, United States

Location

LA General Medical Center

Los Angeles, California, 90033, United States

Location

USC Norris Comprehensive Cancer Center

Los Angeles, California, 90033, United States

Location

MeSH Terms

Conditions

Carcinoma, Hepatocellular

Interventions

Patient Navigation

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsLiver NeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesLiver Diseases

Intervention Hierarchy (Ancestors)

Patient-Centered CarePrimary Health CareComprehensive Health CarePatient Care ManagementHealth Services Administration

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: After informed consent and surveys have been completed, patients will be randomly assigned to one of two study arms: SDOH and patient navigation program or patient navigation only. Randomization will occur on a 2:1 ratio using the permuted block randomization method.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 13, 2026

First Posted

May 5, 2026

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

September 1, 2028

Last Updated

May 5, 2026

Record last verified: 2026-04

Locations